Inogen (INGN) Deferred Taxes (2013 - 2026)
Inogen's (INGN) quarterly Deferred Taxes came in at -$41000.0 in Q1 2026, down 108.97% year-on-year from $457000.0 in Q1 2025, and up 96.37% on a QoQ basis from -$1.1 million in Q4 2025.
Inogen (INGN) Deferred Taxes (2013 - 2026) Analysis & Trends
Inogen (INGN) has 12 years of Deferred Taxes data on file, last reported at -$41000.0 in Q1 2026.
- On a quarterly basis, Deferred Taxes fell 108.97% year-over-year to -$41000.0 in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 224.8% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 million, up 4.35% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$41000.0, up from -$1.1 million in the prior quarter.
- Over the last five years, Deferred Taxes for INGN reached as high as $457000.0 in Q1 2025 and fell as low as -$1.1 million in Q4 2025.
- Historically, Deferred Taxes has averaged -$254555.6 across 3 years, with a median of -$50000.0 in 2025.
- On a YoY basis, Deferred Taxes climbed as much as 327.36% in 2025 and fell as far as 1613.64% in 2025.
- Year by year, Deferred Taxes stood at -$906000.0 in 2024, then retreated by 24.72% to -$1.1 million in 2025, then soared by 96.37% to -$41000.0 in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$41000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$50000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | -41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -377,000.00 |
| Mar 31, 2025 | 457,000.00 |
| Dec 31, 2024 | -906,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -201,000.00 |
| Dec 31, 2021 | 15.46 Mn |
| Sep 30, 2021 | -6.31 Mn |
| Jun 30, 2021 | 6.82 Mn |
| Mar 31, 2021 | -1.53 Mn |
| Dec 31, 2020 | -451,000.00 |
| Sep 30, 2020 | -315,000.00 |
| Jun 30, 2020 | 884,000.00 |
| Mar 31, 2020 | -200,000.00 |
| Dec 31, 2019 | -3.04 Mn |
| Sep 30, 2019 | 1.84 Mn |
| Jun 30, 2019 | 3.23 Mn |